Overview
JINGHUA PHARM (002349)
Jinghua Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceuticals in China a...
- Open
- 6.85
- High
- 6.86
- Low
- 6.75
- Prev. Close
- 6.85
- Volume
- 64.39K
- Turnover
- 43.82M
- Avg Price
- 6.80
- Bid/Ask Ratio
- --
- Amplitude
- 1.61%
- 52wk High
- 9.59
- Volume Ratio
- 0.00
- Turnover Ratio
- 0.79%
- 52wk Low
- 5.99
- Float Mkt Cap
- 5.56B
- Market CapCNY
- 5.68B
- P/ETTM
- 24.40
- P/EDynamic
- 22.44
- P/EStatic
- --
- EPSTTM
- 0.280
- EPSDynamic
- 0.304
- EPSStatic
- --
- BVPS
- 3.47
- P/B
- 1.97
- Circulating Supply
- 814.18M
- Dividend YieldTTM
- 1.32%
- DividendTTM
- 0.09
- Shares
- 831.07M
- Min lot size
- 100
- Currency
- CNY
JINGHUA PHARM Analyst Rating
View moreForecast & Rating
May 11, 2018- Strong buy0.00%
- Buy100.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
- Strong buy
- 0
- Buy
- 1
- Hold
- 0
- Sell
- 0
- Strong sell
- 0
News
Simplywall · Discovering Undiscovered Gems in Global for April 2026
AASTOCKS · "Performance" Novartis' net profit fell 15% last quarter, expects core operating profit to decline for the first time in six years this year
Zhitong · JINGHUA PHARM released its performance for the first three quarters, with a net profit attributable to the parent company of 176 million yuan, a year-on-year increase of 7.39%
Zhitong · JINGHUA PHARM: The company's medical sodium alginate wound dressing has obtained a medical device registration certificate
Zhitong · JINGHUA PHARM's subsidiary LuHuaSenXuan leads the formulation of an industry standard approved by the National Standardization Administration
Zhitong · JINGHUA PHARM: Net profit of 131 million yuan in the first half of 2025, a year-on-year decrease of 3.54%
